Product Images Duloxetine Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Duloxetine Delayed-release NDC 71335-0509 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - duloxetine 01
Figure 1 - duloxetine 02
The graph shows the proportion of patients experiencing relapse over time for two treatments: placebo and duloxetine delayed-release. The x-axis represents the time from randomization to relapse in days, while the y-axis represents the proportion of patients with relapse.*
Figure 2 - duloxetine 03
The graph illustrates the proportion of patients who experienced relapse over time after taking either a placebo or Duloxetine delayed-release capsules. It shows that patients who were treated with Duloxetine had a lower rate of relapse compared to the placebo group. This graph can be useful for healthcare professionals when determining the efficacy of the medication in preventing relapses in patients.*
Figure 3 - duloxetine 04
Figure 4 - duloxetine 05
Figure 5 - duloxetine 06
The text provided only includes a table with no clear information on the context or purpose of the data. Therefore, a useful description cannot be generated.*
Figure 6 - duloxetine 07
Figure 8 - duloxetine 08
This is a chart showing the percentage of patients improved in pain from baseline. The X-axis shows the percent improvement in pain from baseline (BOCF) ranging from 0 to 100. The Y-axis shows the percentage of patients who showed improvement, ranging from 50 to 80 for DUL (duloxetine) 60/120 mg once daily, and 70 for placebo.*
Figure 9 - duloxetine 09
This is a chart showing the percentage of patients who improved after taking either a placebo or DUL, with 10 different measurement points ranging from 0 to 100. The text doesn't provide any details on what DUL is or what kind of pain it treats, but it appears to be a pain medication of some sort that was tested against a placebo. The chart also includes a separate graph showing the percent improvement in pain from baseline using the BOCF method.*
Figure 10 - duloxetine 10
Label - lbl713350509
This appears to be a package information for a generic medication named "Cymbalta 60mg Capsule" packaged by "Bryant Ranck Prepack". The package contains 30 capsules, and the NDC code is 7133505091. The manufacturer of the medication is "Dose Innova, S.L." The expiration date is specified as "MM/YY" format. There are storage instructions provided, and a cautionary note to keep the drugs out of the reach of children. The last line of the text is not related to the medication information and is not readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.